These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23320996)

  • 21. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
    Vogt IR; Lees AJ; Evert BO; Klockgether T; Bonin M; Wüllner U
    Exp Neurol; 2006 Jun; 199(2):465-78. PubMed ID: 16626704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case.
    Takanashi M; Ohta S; Matsuoka S; Mori H; Mizuno Y
    Acta Neuropathol; 2002 Jan; 103(1):82-7. PubMed ID: 11837750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
    Fillon G; Kahle PJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S64-6. PubMed ID: 16092093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive function in multiple system atrophy of the cerebellar type.
    Bürk K; Daum I; Rüb U
    Mov Disord; 2006 Jun; 21(6):772-6. PubMed ID: 16475154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-Based Evaluation of α-Synuclein Pathology in Multiple System Atrophy as a Novel Tool to Recognize Disease Subtypes.
    Kim A; Yoshida K; Kovacs GG; Forrest SL
    Mod Pathol; 2024 Aug; 37(8):100533. PubMed ID: 38852813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple system atrophy: a sporadic synucleinopathy.
    Dickson DW; Lin W; Liu WK; Yen SH
    Brain Pathol; 1999 Oct; 9(4):721-32. PubMed ID: 10517510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expanding concept of clinical conditions and symptoms in multiple system atrophy].
    Watanabe H; Riku Y; Nakamura T; Hara K; Ito M; Hirayama M; Yoshida M; Katsuno M; Sobue G
    Rinsho Shinkeigaku; 2016 Jul; 56(7):457-64. PubMed ID: 27356737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging.
    da Rocha AJ; Maia AC; da Silva CJ; Braga FT; Ferreira NP; Barsottini OG; Ferraz HB
    Mov Disord; 2007 Jan; 22(2):238-44. PubMed ID: 17133514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of multiple system atrophy.
    Fernagut PO; Tison F
    Neuroscience; 2012 Jun; 211():77-82. PubMed ID: 21963351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex families with multiple system atrophy.
    Hara K; Momose Y; Tokiguchi S; Shimohata M; Terajima K; Onodera O; Kakita A; Yamada M; Takahashi H; Hirasawa M; Mizuno Y; Ogata K; Goto J; Kanazawa I; Nishizawa M; Tsuji S
    Arch Neurol; 2007 Apr; 64(4):545-51. PubMed ID: 17420317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second consensus statement on the diagnosis of multiple system atrophy.
    Gilman S; Wenning GK; Low PA; Brooks DJ; Mathias CJ; Trojanowski JQ; Wood NW; Colosimo C; Dürr A; Fowler CJ; Kaufmann H; Klockgether T; Lees A; Poewe W; Quinn N; Revesz T; Robertson D; Sandroni P; Seppi K; Vidailhet M
    Neurology; 2008 Aug; 71(9):670-6. PubMed ID: 18725592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro models of multiple system atrophy.
    Stefanova N; Reindl M; Poewe W; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S53-6. PubMed ID: 16092091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple system atrophy: cellular and molecular pathology.
    Burn DJ; Jaros E
    Mol Pathol; 2001 Dec; 54(6):419-26. PubMed ID: 11724918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathological features of multiple system atrophy with cognitive impairment.
    Asi YT; Ling H; Ahmed Z; Lees AJ; Revesz T; Holton JL
    Mov Disord; 2014 Jun; 29(7):884-8. PubMed ID: 24752994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
    Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy.
    Bassil F; Monvoisin A; Canron MH; Vital A; Meissner WG; Tison F; Fernagut PO
    Mov Disord; 2015 Nov; 30(13):1802-12. PubMed ID: 26260627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.